fludarabine and t140 peptide

fludarabine has been researched along with t140 peptide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burger, JA; Burger, M; Fujii, N; Hartmann, T; Kipps, TJ; Krome, M; Rawluk, J; Tamamura, H	1

Other Studies

1 other study(ies) available for fludarabine and t140 peptide

Article	Year
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood, 2005, Sep-01, Volume: 106, Issue:5 Topics: Actins; Apoptosis; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mitogen-Activated Protein Kinases; Molecular Weight; Oligopeptides; Peptides; Receptors, CXCR4; Stromal Cells; Structure-Activity Relationship; Time Factors; Vidarabine	2005

Article

Year

Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.

Blood, 2005, Sep-01, Volume: 106, Issue:5

Topics: Actins; Apoptosis; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mitogen-Activated Protein Kinases; Molecular Weight; Oligopeptides; Peptides; Receptors, CXCR4; Stromal Cells; Structure-Activity Relationship; Time Factors; Vidarabine

2005